ICHOR HOLDINGS LTD (ICHR) Stock Fundamental Analysis
USA - NASDAQ:ICHR - KYG4740B1059 - Common Stock
17.68 USD
-0.68 (-3.7%)
17.6003 USD
-0.08 (-0.45%)
Taking everything into account, ICHR scores 3 out of 10 in our fundamental rating. ICHR was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. ICHR has a bad profitability rating. Also its financial health evaluation is rather negative. ICHR is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
ICHR had positive earnings in the past year.
In the past year ICHR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ICHR reported negative net income in multiple years.
In the past 5 years ICHR always reported a positive cash flow from operatings.
1.2 Ratios
ICHR has a Return On Assets of -2.10%. This is in the lower half of the industry: ICHR underperforms 60.71% of its industry peers.
ICHR's Return On Equity of -2.98% is in line compared to the rest of the industry. ICHR outperforms 41.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.1% | ||
| ROE | -2.98% | ||
| ROIC | N/A |
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of ICHR (11.89%) is worse than 87.50% of its industry peers.
In the last couple of years the Gross Margin of ICHR has declined.
ICHR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 11.89% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
2. Health
2.1 Basic Checks
ICHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
ICHR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ICHR has been increased compared to 5 years ago.
Compared to 1 year ago, ICHR has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.78 indicates that ICHR is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ICHR (2.78) is comparable to the rest of the industry.
ICHR has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
ICHR has a Debt to Equity ratio of 0.17. This is comparable to the rest of the industry: ICHR outperforms 48.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.78 |
ROIC/WACCN/A
WACC11.3%
2.3 Liquidity
ICHR has a Current Ratio of 3.22. This indicates that ICHR is financially healthy and has no problem in meeting its short term obligations.
ICHR has a Current ratio (3.22) which is in line with its industry peers.
ICHR has a Quick Ratio of 1.32. This is a normal value and indicates that ICHR is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.32, ICHR is not doing good in the industry: 82.14% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.22 | ||
| Quick Ratio | 1.32 |
3. Growth
3.1 Past
ICHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1266.67%, which is quite impressive.
ICHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -33.82% yearly.
ICHR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.44%.
ICHR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.46% yearly.
EPS 1Y (TTM)1266.67%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%-40%
Revenue 1Y (TTM)15.44%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%18.23%
3.2 Future
Based on estimates for the next years, ICHR will show a very strong growth in Earnings Per Share. The EPS will grow by 73.13% on average per year.
Based on estimates for the next years, ICHR will show a quite strong growth in Revenue. The Revenue will grow by 8.59% on average per year.
EPS Next Y184.41%
EPS Next 2Y173.11%
EPS Next 3Y106.44%
EPS Next 5Y73.13%
Revenue Next Year12.47%
Revenue Next 2Y9.09%
Revenue Next 3Y8.94%
Revenue Next 5Y8.59%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 50.51, ICHR can be considered very expensive at the moment.
ICHR's Price/Earnings ratio is in line with the industry average.
ICHR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.29.
The Price/Forward Earnings ratio is 14.81, which indicates a correct valuation of ICHR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ICHR indicates a rather cheap valuation: ICHR is cheaper than 91.96% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.80. ICHR is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50.51 | ||
| Fwd PE | 14.81 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ICHR is valued a bit cheaper than 65.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 27.25 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ICHR's earnings are expected to grow with 106.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.27
PEG (5Y)N/A
EPS Next 2Y173.11%
EPS Next 3Y106.44%
5. Dividend
5.1 Amount
No dividends for ICHR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
17.68
-0.68 (-3.7%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners99.16%
Inst Owner Change0.49%
Ins Owners2.07%
Ins Owner Change21.13%
Market Cap606.95M
Analysts78.46
Price Target24.65 (39.42%)
Short Float %6.23%
Short Ratio2.49
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-67.14%
Min EPS beat(2)-79.27%
Max EPS beat(2)-55.02%
EPS beat(4)1
Avg EPS beat(4)-33.43%
Min EPS beat(4)-79.27%
Max EPS beat(4)10.09%
EPS beat(8)2
Avg EPS beat(8)-597.61%
EPS beat(12)5
Avg EPS beat(12)-369.48%
EPS beat(16)6
Avg EPS beat(16)-277.99%
Revenue beat(2)1
Avg Revenue beat(2)-0.85%
Min Revenue beat(2)-2.16%
Max Revenue beat(2)0.45%
Revenue beat(4)2
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)1.83%
Revenue beat(8)5
Avg Revenue beat(8)-0.11%
Revenue beat(12)7
Avg Revenue beat(12)-0.07%
Revenue beat(16)8
Avg Revenue beat(16)-0.38%
PT rev (1m)-6.45%
PT rev (3m)-17.14%
EPS NQ rev (1m)-8.69%
EPS NQ rev (3m)-50.57%
EPS NY rev (1m)0%
EPS NY rev (3m)-41.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50.51 | ||
| Fwd PE | 14.81 | ||
| P/S | 0.65 | ||
| P/FCF | N/A | ||
| P/OCF | 35.59 | ||
| P/B | 0.87 | ||
| P/tB | 1.93 | ||
| EV/EBITDA | 27.25 |
EPS(TTM)0.35
EY1.98%
EPS(NY)1.19
Fwd EY6.75%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)0.5
OCFY2.81%
SpS27.07
BVpS20.22
TBVpS9.15
PEG (NY)0.27
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.1% | ||
| ROE | -2.98% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 11.89% | ||
| FCFM | N/A |
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
F-Score6
Asset Turnover0.94
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 5.01 | ||
| Cap/Depr | 115.9% | ||
| Cap/Sales | 3.88% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 72.65% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.22 | ||
| Quick Ratio | 1.32 | ||
| Altman-Z | 2.78 |
F-Score6
WACC11.3%
ROIC/WACCN/A
Cap/Depr(3y)62.01%
Cap/Depr(5y)61.74%
Cap/Sales(3y)2.1%
Cap/Sales(5y)1.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1266.67%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%-40%
EPS Next Y184.41%
EPS Next 2Y173.11%
EPS Next 3Y106.44%
EPS Next 5Y73.13%
Revenue 1Y (TTM)15.44%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%18.23%
Revenue Next Year12.47%
Revenue Next 2Y9.09%
Revenue Next 3Y8.94%
Revenue Next 5Y8.59%
EBIT growth 1Y59.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year255.23%
EBIT Next 3Y56.45%
EBIT Next 5Y48.64%
FCF growth 1Y-139.16%
FCF growth 3YN/A
FCF growth 5Y-22.51%
OCF growth 1Y-77.09%
OCF growth 3Y22.22%
OCF growth 5Y-13.37%